Medicine – Hypomagnesaemia

Hypomagnesaemia means an abnormally low concentration of magnesium in the blood. Magnesium is an important intracellular cation involved in neuromuscular function, cardiac electrical stability, enzyme activity, potassium regulation and calcium homeostasis.

Hypomagnesaemia is particularly important clinically because it frequently occurs together with:

Hypokalaemia – low K⁺

and

Hypocalcaemia – low Ca²⁺.

Severe deficiency can produce potentially life-threatening cardiac and neurological complications.

1. Normal Magnesium Physiology

Most magnesium in the body is located within:

Bone.

Muscle.

Other intracellular tissues.

Only a small proportion is present in extracellular fluid and measurable in serum.

Therefore, serum magnesium does not always perfectly reflect:

Total body magnesium stores.

2. Regulation of Magnesium

Magnesium balance depends mainly on:

Gastrointestinal absorption

and

Renal excretion.

The kidneys are particularly important because they can alter urinary magnesium excretion according to the body’s requirements.

Therefore hypomagnesaemia usually results from either:

Gastrointestinal magnesium loss

or

Renal magnesium wasting.

3. Hypomagnesaemia and Hypokalaemia

The original notes correctly state that hypomagnesaemia is commonly associated with:

Low K⁺.

Magnesium deficiency promotes renal potassium wasting.

Normally intracellular magnesium helps regulate potassium secretion through renal potassium channels.

When magnesium is deficient:

Renal K⁺ loss increases.

Therefore:

Hypomagnesaemia → renal potassium wasting → hypokalaemia.

4. Refractory Hypokalaemia

This relationship has an important clinical consequence.

If a patient has:

Hypokalaemia + hypomagnesaemia,

giving potassium alone may fail to correct the potassium concentration adequately.

Therefore:

REFRACTORY HYPOKALAEMIA → ALWAYS CONSIDER MAGNESIUM DEFICIENCY.

Magnesium replacement is often required before or alongside potassium replacement.

5. Hypomagnesaemia and Hypocalcaemia

Hypomagnesaemia can also produce:

Hypocalcaemia.

Severe magnesium deficiency interferes with:

Parathyroid hormone – PTH secretion

and can also cause:

Resistance to the actions of PTH.

The result is impaired calcium homeostasis.

Therefore:

Severe ↓ Mg²⁺ → ↓ PTH secretion/action → ↓ Ca²⁺.

6. Refractory Hypocalcaemia

As with potassium, calcium may be difficult to correct when significant magnesium deficiency remains untreated.

Therefore:

HYPOCALCAEMIA + HYPOKALAEMIA TOGETHER → CHECK MAGNESIUM.

This is a particularly useful clinical clue.

7. Neuromuscular Manifestations

Magnesium deficiency increases neuromuscular excitability.

Patients may develop:

Muscle cramps.

Muscle weakness.

Tremor.

Hyperreflexia.

Paraesthesiae.

Tetany.

Severe deficiency may cause:

Seizures – fits.

8. Paraesthesiae and Tetany

The original notes correctly include:

Paraesthesiae

and

Tetany.

Tetany may result from the combined effects of:

Magnesium deficiency

and associated:

Hypocalcaemia.

Patients may therefore develop tingling around the mouth or extremities, muscle spasms and increased neuromuscular irritability.

9. Seizures

Severe hypomagnesaemia can cause:

Seizures.

This occurs because magnesium plays an important role in stabilising neuronal membranes and regulating neuronal excitability.

Therefore severe magnesium deficiency should be considered among the metabolic causes of:

Acute seizures.

10. Cardiac Manifestations

One of the most important consequences of hypomagnesaemia is:

Cardiac electrical instability.

Magnesium participates in normal myocardial ion-channel function and cardiac repolarisation.

Deficiency therefore increases susceptibility to:

Cardiac arrhythmias.

11. Ventricular Arrhythmias

The original notes correctly associate hypomagnesaemia with:

Ventricular arrhythmias.

The risk becomes particularly important when hypomagnesaemia coexists with:

Hypokalaemia.

12. Torsades de Pointes

A particularly important association is:

Torsades de pointes.

This is a polymorphic ventricular tachycardia associated with:

QT prolongation.

Magnesium is therefore used therapeutically for torsades de pointes, even in some patients whose measured serum magnesium is not markedly reduced.

13. Causes of Hypomagnesaemia

The major mechanisms can be organised into:

Gastrointestinal loss or impaired absorption.

Renal magnesium loss.

Redistribution or metabolic causes.

Alcohol-related deficiency.

Drug-induced magnesium wasting.

14. Renal Magnesium Loss

The kidneys normally conserve magnesium when body stores are low.

If renal tubular handling is impaired, excessive magnesium is lost in:

Urine.

This produces:

Renal magnesium wasting.

Causes include certain medications, hypercalcaemia and inherited renal tubular disorders.

15. Gastrointestinal Loss

The gastrointestinal tract is another major source of magnesium loss.

Important causes include:

High-volume diarrhoea

and

Malabsorption.

16. High-Volume Diarrhoea

The original notes correctly include:

High-volume diarrhoea.

Prolonged diarrhoea causes direct gastrointestinal loss of magnesium.

It may simultaneously cause losses of:

Potassium.

Bicarbonate.

Water.

Therefore a patient with severe diarrhoea may develop:

Hypomagnesaemia + hypokalaemia + metabolic acidosis.

17. Malabsorption

Conditions causing chronic malabsorption can reduce intestinal magnesium absorption.

Examples include:

Coeliac disease.

Inflammatory bowel disease with significant intestinal involvement or resection.

Short-bowel syndrome.

Chronic severe diarrhoeal disorders.

Therefore chronic gastrointestinal disease may gradually deplete total body magnesium.

18. Hypercalcaemia

The original notes include:

Hypercalcaemia.

This is a recognised cause of renal magnesium wasting.

High calcium concentrations can interfere with magnesium reabsorption in the nephron, particularly in the:

Thick ascending limb of the loop of Henle.

Therefore:

Hypercalcaemia → ↑ renal Mg²⁺ loss → hypomagnesaemia.

19. Diabetic Ketoacidosis

The original notes correctly include:

Diabetic ketoacidosis – DKA.

Patients with DKA often have significant total-body electrolyte depletion due to:

Osmotic diuresis.

This causes urinary losses of:

Water.

Potassium.

Magnesium.

Phosphate.

20. Magnesium in DKA

Even when the initial serum magnesium is not dramatically low, the patient’s:

Total body magnesium stores may be depleted.

Treatment with insulin and correction of the metabolic disturbance can alter extracellular concentrations further.

Therefore electrolytes require careful monitoring during DKA treatment.

21. Alcohol

The original notes correctly identify:

Alcohol

as an important cause.

Chronic alcohol use can produce magnesium deficiency through several mechanisms.

These include:

Poor nutritional intake.

Gastrointestinal losses.

Renal magnesium wasting.

Associated pancreatitis or diarrhoea may contribute further.

22. Alcohol and Multiple Electrolyte Abnormalities

Patients with chronic heavy alcohol exposure may simultaneously develop:

Hypomagnesaemia.

Hypokalaemia.

Hypophosphataemia.

Other nutritional deficiencies may also coexist.

Therefore magnesium should be checked in patients with alcohol-related illness and unexplained electrolyte abnormalities.

23. Drug-Induced Hypomagnesaemia

Several medications can cause magnesium depletion by increasing:

Renal magnesium excretion

or reducing:

Intestinal magnesium absorption.

The original notes correctly include:

Loop/thiazide diuretics.

Aminoglycosides.

Cisplatin.

Ciclosporin.

24. Loop Diuretics

Loop diuretics such as:

Furosemide

reduce sodium, potassium and chloride reabsorption in the thick ascending limb.

They can also increase urinary loss of:

Magnesium

and

Calcium.

Therefore prolonged or intensive loop-diuretic treatment may contribute to:

Hypomagnesaemia.

25. Thiazide Diuretics

Thiazide diuretics can also increase:

Renal magnesium loss.

Chronic therapy may therefore produce:

Hypomagnesaemia, particularly in susceptible patients.

Remember the calcium distinction:

Loop diuretics → ↑ urinary Ca²⁺.

Thiazides → ↓ urinary Ca²⁺.

But both can contribute to:

Magnesium loss.

26. Aminoglycosides

Aminoglycoside antibiotics can cause renal tubular toxicity.

Examples include:

Gentamicin.

Amikacin.

Tobramycin.

Tubular injury can impair magnesium reabsorption and produce:

Renal magnesium wasting.

27. Cisplatin

The chemotherapy agent:

Cisplatin

is an important cause of hypomagnesaemia.

It can damage renal tubular cells and produce persistent:

Renal magnesium wasting.

The magnesium deficiency may sometimes persist even after cisplatin treatment has finished.

28. Ciclosporin

Ciclosporin can also promote renal magnesium loss.

This is particularly relevant in patients receiving:

Immunosuppressive therapy, including transplant recipients.

Other calcineurin inhibitors, particularly:

Tacrolimus,

can have a similar effect.

29. Proton-Pump Inhibitors – Important Additional Cause

A major modern addition to the original list is:

Proton-pump inhibitors – PPIs.

Long-term PPI therapy can occasionally cause significant hypomagnesaemia by impairing:

Intestinal magnesium absorption.

Examples include:

Omeprazole.

Esomeprazole.

Pantoprazole.

Therefore unexplained persistent hypomagnesaemia should prompt review of:

PPI use.

30. Inherited Renal Causes

Certain inherited renal tubular disorders also produce magnesium loss.

An important example is:

Gitelman syndrome.

Gitelman syndrome typically causes:

Hypokalaemia.

Metabolic alkalosis.

Hypomagnesaemia.

Hypocalciuria.

31. Gitelman Syndrome

The renal defect resembles chronic exposure to a:

Thiazide diuretic.

Therefore:

GITELMAN → LOW K⁺ + LOW Mg²⁺ + METABOLIC ALKALOSIS + LOW URINARY Ca²⁺.

This is a useful examination pattern.

32. Clinical Features – Note Form

Cardiac:

Ventricular arrhythmias.

QT abnormalities.

Torsades de pointes.

Neurological:

Seizures.

Tremor.

Hyperreflexia.

Neuromuscular:

Tetany.

Muscle cramps.

Paraesthesiae.

Weakness.

Associated biochemical abnormalities:

Hypokalaemia.

Hypocalcaemia.

33. Causes – Note Form

Gastrointestinal loss:

High-volume diarrhoea.

Malabsorption.

Short-bowel states.

Renal loss:

Renal tubular disorders.

Hypercalcaemia.

Metabolic:

DKA with osmotic diuresis.

Alcohol:

Poor intake + GI loss + renal wasting.

Drugs:

Loop diuretics.

Thiazide diuretics.

Aminoglycosides.

Cisplatin.

Ciclosporin.

Tacrolimus.

Long-term PPIs.

34. Investigation

When hypomagnesaemia is identified, assessment should include:

Serum magnesium.

Potassium.

Calcium.

Renal function.

Other electrolytes may also be appropriate depending on the clinical situation.

35. Distinguishing Renal From Gastrointestinal Loss

If the cause is uncertain, urinary magnesium measurements can help determine whether the kidneys are appropriately conserving magnesium.

Conceptually:

Low urinary Mg²⁺ in hypomagnesaemia → kidneys are conserving magnesium → consider GI loss or poor intake.

In contrast:

Inappropriately high urinary Mg²⁺ → renal magnesium wasting.

This distinction can help identify the underlying mechanism.

36. Treatment

Treatment depends on:

Severity.

Symptoms.

Underlying cause.

Renal function.

Mild or asymptomatic deficiency can often be treated with:

Oral magnesium replacement.

37. Severe or Symptomatic Hypomagnesaemia

Severe deficiency associated with:

Seizures.

Tetany.

Significant ventricular arrhythmias.

may require:

Intravenous magnesium, commonly magnesium sulfate, with appropriate monitoring.

The underlying cause should also be corrected.

38. Correct Associated Electrolyte Abnormalities

If the patient also has:

Hypokalaemia

or

Hypocalcaemia,

magnesium deficiency should be corrected because these abnormalities may otherwise remain:

Refractory to treatment.

Therefore:

LOW Mg²⁺ + LOW K⁺ → REPLACE Mg²⁺ AS WELL AS K⁺.

39. Important Clarifications to the Original Notes

The statement:

“Usually associated with low Ca²⁺ and low K⁺”

is useful clinically, although not every patient will have both abnormalities.

The mechanisms are different:

Low Mg²⁺ → renal K⁺ wasting → hypokalaemia.

Severe low Mg²⁺ → impaired PTH secretion/action → hypocalcaemia.

The listed manifestations:

Ventricular arrhythmias, fits, tetany and paraesthesiae

are correct.

A particularly important cardiac complication to remember is:

TORSADES DE POINTES.

The original causes are also appropriate:

Renal loss.

High-volume diarrhoea.

Malabsorption.

Hypercalcaemia.

DKA.

Alcohol.

Loop/thiazide diuretics.

Aminoglycosides.

Cisplatin.

Ciclosporin.

Important modern additions include:

PPIs, tacrolimus and inherited renal tubular disorders such as Gitelman syndrome.

Key Clinical Pattern

For rapid recall:

HYPOMAGNESAEMIA → NEUROMUSCULAR EXCITABILITY + CARDIAC INSTABILITY.

Think:

BRAIN → SEIZURES.

NERVES/MUSCLES → PARAESTHESIAE + TETANY + TREMOR.

HEART → VENTRICULAR ARRHYTHMIAS + TORSADES.

ELECTROLYTES → ↓ K⁺ + ↓ Ca²⁺.

For the mechanism:

LOW Mg²⁺ → RENAL K⁺ WASTING → REFRACTORY HYPOKALAEMIA.

SEVERE LOW Mg²⁺ → ↓ PTH SECRETION/ACTION → HYPOCALCAEMIA.

For causes:

GI LOSS → DIARRHOEA / MALABSORPTION.

RENAL LOSS → DIURETICS / AMINOGLYCOSIDES / CISPLATIN / CALCINEURIN INHIBITORS / HYPERCALCAEMIA.

METABOLIC → DKA.

ALCOHOL → POOR INTAKE + GI LOSS + RENAL WASTING.

DRUG ABSORPTION PROBLEM → LONG-TERM PPI USE.

And the high-yield clinical rule is:

HYPOKALAEMIA THAT WILL NOT CORRECT → CHECK AND CORRECT MAGNESIUM.